Results 291 to 300 of about 9,217,738 (367)

Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non‐psychological) strategies to address Cognitive Impairment Associated with ...
Bahareh Peyrovian, Lena Palaniyappan, Theodore T. Kolivakis, Howard C. Margolese   +3 more
wiley   +1 more source

Audiovestibular Dysfunction in Patients with Hashimoto's Disease: A Systematic Review. [PDF]

Int J Mol Sci
Chen JJ, Hsu CW, Chen TY, Liang CS, Chen YW, Zeng BY, Tseng PT.   +6 more
europepmc   +1 more source

Learning to Love Rats: A Postwar Ecology in a Cambodian Minefield

American Anthropologist, EarlyView.
ABSTRACT This paper follows the implementation of landmine detection rats in Cambodia. Over the course of my ethnographic fieldwork with the team for the landmine detection rat technique training in Cambodia, I saw that the way the human landmine detectors (a.k.a.
Darcie DeAngelo
wiley   +1 more source

Impact of haemodialysis on vestibular function in adult patients with chronic kidney disease. [PDF]

Acta Otorhinolaryngol Ital
Viola P, De Luca P, Scarpa A, Ricciardiello F, Gioacchini FM, Anzivino R, Barbara F, Astorina A, Zicarelli M, Avallone E, Coppolino G, Andreucci M, Chiarella G.   +12 more
europepmc   +1 more source

Antimicrobial prescribing guidelines for horses in Australia

Australian Veterinary Journal, EarlyView.
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt, K Thomas, S Page, J Norris, G Browning, C El Hage, A Stewart, J Gilkerson, G Muscatello, D Verwilghen, G van Galen, J Bauquier, R Cuming, B Reynolds, C Whittaker, E Wilkes, J Clulow, C Burden, L Begg   +18 more
wiley   +1 more source

Magnetic Resonance Imaging of Endolymphatic Hydrops Using Compressed Sensing Acceleration Technique. [PDF]

Cureus
Kimura Y, Ceballos-Lizarraga R, Soto-Trujillo D, Cristancho-Rojas CN.   +3 more
europepmc   +1 more source

Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice

British Journal of Pharmacology, EarlyView.
Background and Purpose Migraine is a neurovascular disorder largely mediated by calcitonin gene‐related peptide (CGRP). This study explores the role of the nociceptin/orphanin FQ (N/OFQ)–N/OFQ receptor (NOP) system in CGRP‐induced periorbital mechanical allodynia (PMA) in mice.
Chiara Sturaro, Pietro Pola, Michela Argentieri, Alessia Frezza, Matilde Marini, Francesco De Logu, Valentina Albanese, Marie Soukupova, Davide Malfacini, Nurulain T. Zaveri, Romina Nassini, Dane D. Jensen, Pierangelo Geppetti, Girolamo Calò, Chiara Ruzza   +14 more
wiley   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

Modeling of magnetic vestibular stimulation experienced during high-field clinical MRI. [PDF]

Commun Med (Lond)
Arán-Tapia I, Pérez-Muñuzuri V, Muñuzuri AP, Soto-Varela A, Otero-Millan J, Roberts DC, Ward BK.   +6 more
europepmc   +1 more source

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

Clinical and Experimental Neuroimmunology, EarlyView.
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa, Ema Rodrigues, Hiroyuki Murai   +2 more
wiley   +1 more source